TradeOrgs
  • Stocks
  • Screener
  • Backtest
  • Watchlist
  • Signals
  • Portfolio
  • Insights
  • Connect
Sign in
RELIANCE₹1,304.00▼ 0.70%TCS₹2,093.50▼ 6.61%HDFCBANK₹801.05▲ 6.29%ICICIBANK₹1,411.40▲ 13.64%INFY₹1,047.20▼ 14.35%HINDUNILVR₹2,201.20▲ 5.29%ITC₹289.95▲ 4.68%SBIN₹1,040.00▲ 7.17%BHARTIARTL₹1,910.40▲ 4.73%KOTAKBANK₹396.75▲ 4.13%LT₹4,026.60▲ 1.86%AXISBANK₹1,342.10▲ 6.92%ASIANPAINT₹2,737.80▲ 2.83%MARUTI₹14,366.00▲ 10.13%AAPL$308.63▼ 2.08%MSFT$390.49▼ 11.52%GOOGL$359.91▼ 0.54%AMZN$242.67▼ 5.40%NVDA$194.83▼ 12.56%META$582.90▼ 2.46%TSLA$393.45▼ 7.15%BRK-B$507.78▲ 7.69%JPM$334.47▲ 11.13%V$362.13▲ 14.12%
RELIANCE₹1,304.00▼ 0.70%TCS₹2,093.50▼ 6.61%HDFCBANK₹801.05▲ 6.29%ICICIBANK₹1,411.40▲ 13.64%INFY₹1,047.20▼ 14.35%HINDUNILVR₹2,201.20▲ 5.29%ITC₹289.95▲ 4.68%SBIN₹1,040.00▲ 7.17%BHARTIARTL₹1,910.40▲ 4.73%KOTAKBANK₹396.75▲ 4.13%LT₹4,026.60▲ 1.86%AXISBANK₹1,342.10▲ 6.92%ASIANPAINT₹2,737.80▲ 2.83%MARUTI₹14,366.00▲ 10.13%AAPL$308.63▼ 2.08%MSFT$390.49▼ 11.52%GOOGL$359.91▼ 0.54%AMZN$242.67▼ 5.40%NVDA$194.83▼ 12.56%META$582.90▼ 2.46%TSLA$393.45▼ 7.15%BRK-B$507.78▲ 7.69%JPM$334.47▲ 11.13%V$362.13▲ 14.12%

TradeOrgs shows market information and analyzes your own trading history. It does not place trades and is not investment advice.

Prices and listings are for information only. We are read-only against your broker account.

Technical signals (RSI, MACD, etc.) are educational readouts of public indicators — not recommendations.

Privacy Policy·© 2026 TradeOrgs

← All stocks

🇮🇳BAJAJHCARE

BAJAJHCARE

NSE
₹344.60
▲ ₹45.90 (+15.4%)
Live· just now
delayed feed · not for order timing

Price history · 20-day (cyan) / 50-day (purple) avg

as of 03 Jul 2026
H ₹434.85L ₹272.35-17.1%
₹434.85₹402.35₹369.85₹337.35₹304.85₹272.35₹344.6
RSI (14)
Intraday · 15-minBuy+20RSI 54SidewaysMACD Bullishfor day-trading context — not advice

Technical signal

Buy+30
RSI (14)64
oversold 30overbought 70
Trend
Uptrend
MACD
Bullish
Bollinger
Within bands
vs 20-day
above
vs 50-day
above
vs 200-day
below
Support
₹281.10
Resistance
₹364.60
  • Price is above its 50-day average (medium-term uptrend).

Educational technical indicators — not investment advice. TradeOrgs does not place trades.

Signal backtest · 2025-09-29 → 2026-07-03

Strategy return
-22.7%
Buy & hold
-29.7%
Trades
6
Win rate
17%

₹1,00,000.00 invested would be worth ₹77,330.64 (-22.7%) · Full backtester →

Hypothetical: go long when the signal turns Buy, exit when it turns Sell. Past indicator behavior is not a prediction — educational only, not advice.

About Bajaj HealthCare Limited· Drug Manufacturers - Specialty & Generic

source: yahoo

Bajaj HealthCare Limited, a pharmaceutical company, develops, manufactures, markets, and sells active pharmaceutical ingredient, intermediates, and finished dosage forms and nutraceuticals for pharmaceutical, nutraceuticals, and food industries in India and internationally. The company offers active pharmaceutical ingredient in various therapeutic categories, including anti-diabetic, antibiotic, antiviral, antiplatelet, antifungal, antihelmintic, iron-chelating agent, anticonvulsant, growth stimulant, non-steroidal anti-inflammatory drugs, antihypertensive, anthelmintics, anti-asthmatic, antioxidant, urinary tract infection, anti-histamine, weight reducing, phlebotropic drug, antimalarial, vitamin c, disinfectant/ antiseptic, stimulant, lipotropic agents, nootropic, vasoprotective/antihemorrhagic, cardiovascular agents, food supplements, anti-anemic, amino acids, antiasthmatic / bronchodilator, nutritional supplement, and minerals. It provides intermediates, such as guanine, 3-methyl xanthine, bromoethyl theophylline, calcium phosphoryl choline chloride, 4-hydrazinobenzoic acid, ticagrelor acetonide, 4,7-dichloroquinolone, 5-[N-ethyl-N-(2-hydroxyethyl)amino]-2-aminopentane, 2-amino -4-hydroxyacetophenone, 8- chloro theophylline, 8 bromo-3-methyl xanthine, 3-methyl-7-(2-butyn-1-yl)-8-bromo xanthine, (S)-1-(2-chloroacetyl)pyrrolidine-2-carbonitrile, 3 – amino – 1 – adamantanol, N – boc -sitagliptin, sitagliptin base, hesperidine, (2,7-dichlori-9H-fluorene), (2-Chloro-1-(2,7- dichlori-9H-fluoren-4-yl)ethanone), (2-(dibutylamino)-1-(2, 7- dichlori-9H-fluoren-4-yl)ethanol), (2-Nitro-4-thiocyanoaniline), 4- (propylthio) benzene -1,2-diamine, methyl [(E)amino(methylsulfanyl)methylidene] carbamate, and (2-phenoxy methane sulphonamide). In addition, the company offers formulations in the form of tablets, capsules, sachets, and vials, as well as impurities. Bajaj HealthCare Limited was incorporated in 1993 and is based in Thane, India.

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Headquarters
Thane, India
www.bajajhealth.com ↗

Fundamentals

source: yahoo
Market cap
₹1.16KCr
P/E
51.3
P/B
2.1
EPS
₹6.72
Div yield
0.3%
Profit margin
2.6%
ROE
4.3%
Debt / Equity
0.47
Beta
0.18
52-week range
₹272.35 – ₹552.60
52-week low · ₹272.3526% of rangehigh · ₹552.60

Fundamental data is informational only — not investment advice.

Recent news

News sentiment:— Neutral0↑ · 0↓ · 8–
  • Canada invests in clean energy in Alberta and Saskatchewan— Neutral
    CNW Group · 04 Jul 2026
  • New "Western Transmission Catalysts" initiative to expand interprovincial transmission across Western Canada— Neutral
    CNW Group · 04 Jul 2026
  • CG Semi Commences Commercial Production at Its G1 OSAT Facility in Sanand, Gujarat— Neutral
    Business Wire · 04 Jul 2026
  • Is SpaceX Stock Officially Overvalued?
— Neutral
Motley Fool · 04 Jul 2026
  • 3 Reasons the Trump Bull Market Can Implode in the Second Half of 2026— Neutral
    Motley Fool · 04 Jul 2026
  • 14th World Peace Forum Calls for International Security Cooperation in Global Peace— Neutral
    PR Newswire · 04 Jul 2026
  • Sentiment is a keyword-based read of the headline — a rough signal, not advice.